BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24120286)

  • 1. [Indications for prophylactic hysterectomy].
    Garabedian C; Lejeune S; Merlot B; Kerdraon O; Boulanger L; Collinet P
    Gynecol Obstet Fertil; 2013 Oct; 41(10):620-3. PubMed ID: 24120286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
    Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
    N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.
    Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK
    Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
    Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
    Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gynecological surveillance of women with Lynch syndrome in Sweden.
    Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
    Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome.
    Lachiewicz MP; Kravochuck SE; O'Malley MM; Heald B; Church JM; Kalady MF; Drake RD
    Gynecol Oncol; 2014 Feb; 132(2):434-7. PubMed ID: 24211399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylactic hysterectomy in Lynch syndrome: Feasibility and outcomes].
    Pacelli J; Gosset M; Rossi L; Ngo C; Delomenie M; Nos C; Lécuru F; Bats AS
    Gynecol Obstet Fertil Senol; 2019 Jun; 47(6):497-503. PubMed ID: 31003015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary peritoneal cancer in Lynch syndrome: a clinical-pathologic report of a case and analysis of the literature.
    Ghezzi F; Uccella S; Cromi A; Bogani G; Donadello N; Riva C
    Int J Gynecol Pathol; 2013 Mar; 32(2):163-6. PubMed ID: 23370650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic surgery prevents endometrial and ovarian cancer in Lynch syndrome.
    Lynch HT; Casey MJ
    Nat Clin Pract Oncol; 2007 Dec; 4(12):672-3. PubMed ID: 17971803
    [No Abstract]   [Full Text] [Related]  

  • 12. Reducing the risk of gynecologic cancer in the Lynch syndrome.
    Offit K; Kauff ND
    N Engl J Med; 2006 Jan; 354(3):293-5. PubMed ID: 16421372
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.
    Shaw PA; Clarke BA
    Surg Pathol Clin; 2016 Jun; 9(2):307-28. PubMed ID: 27241111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study.
    Segev Y; Iqbal J; Lubinski J; Gronwald J; Lynch HT; Moller P; Ghadirian P; Rosen B; Tung N; Kim-Sing C; Foulkes WD; Neuhausen SL; Senter L; Singer CF; Karlan B; Ping S; Narod SA;
    Gynecol Oncol; 2013 Jul; 130(1):127-31. PubMed ID: 23562522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lynch syndrome and gynaecologic's cancer: follow-up recommendations].
    Magri K; Millon G
    J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):68-71. PubMed ID: 17293255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.
    Lu KH
    Fam Cancer; 2008; 7(1):53-8. PubMed ID: 17636427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.
    Beiner ME; Finch A; Rosen B; Lubinski J; Moller P; Ghadirian P; Lynch HT; Friedman E; Sun P; Narod SA;
    Gynecol Oncol; 2007 Jan; 104(1):7-10. PubMed ID: 16962648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer prophylaxis for women with Lynch syndrome.
    Ahmad K
    Lancet Oncol; 2006 Mar; 7(3):200. PubMed ID: 16538784
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prophylactic surgery in common hereditary cancer syndromes].
    Noguès C; Mouret-Fourme E
    Bull Acad Natl Med; 2012 Oct; 196(7):1237-45. PubMed ID: 23815011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic predisposition in gynecologic cancers.
    Daniels MS; Lu KH
    Semin Oncol; 2016 Oct; 43(5):543-547. PubMed ID: 27899185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.